Clinical Trial Update: A Study to Assess the Efficacy and Safety of HRG2005 Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating HRG2005 inhalation for chronic obstructive pulmonary disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• HRG2005

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: TERMINATED